What is Akums Drugs and Pharmaceuticals Net Margin %?
Akums Drugs and PharmaceuticalsNSE:AKUMS +1.24%39 Net Margin % is 7.31% as of Mar. 2026, which is 101% above its 10-year median of 3.64. GuruFocus rates NSE:AKUMS with a GF Score™ of 39/100. The stock has 7 warning signs investors should review. Among 954 Drug Manufacturers companies, Akums Drugs and Pharmaceuticals ranks better than 50.63% on this metric.
The historical rank and industry rank for Akums Drugs and Pharmaceuticals's Net Margin % or its related term are showing as below:
NSE:AKUMS'
s Net Margin % Range Over the Past 10 Years
Min: -6.92 Med: 3.64 Max: 8.31
Current: 5.85
NSE:AKUMS's Net Margin % is ranked better than 50.63% of 954
companies
in the Drug Manufacturers industry
Industry Median: 5.695
vs NSE:AKUMS: 5.85
Akums Drugs and Pharmaceuticals (NSE:AKUMS) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Akums Drugs and Pharmaceuticals Net Margin % Related Terms
Akums Drugs and Pharmaceuticals Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akums Drugs and Pharmaceuticals Net Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Akums Drugs and Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akums Drugs and Pharmaceuticals Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Akums Drugs and Pharmaceuticals's Net Margin % distribution charts can be found below:
* The bar in red indicates where Akums Drugs and Pharmaceuticals's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akums Drugs and Pharmaceuticals (NSE:AKUMS) has a Net Margin % of 7.31% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Akums Drugs and Pharmaceuticals and its competitors. This is 101% above median its historical median of 3.64. According to the industry distribution chart, Akums Drugs and Pharmaceuticals ranks #471 out of 954 companies in the Drug Manufacturers industry, placing it in the top 49.4%.
Is Akums Drugs and Pharmaceuticals' Net Margin % too high?
Akums Drugs and Pharmaceuticals' current Net Margin % of 7.31% is 101% above median its 10-year median of 3.64. The Drug Manufacturers industry median Net Margin % is 5.70. Akums Drugs and Pharmaceuticals' value of 7.31% is 28.4% above this industry median. Based on the distribution chart, Akums Drugs and Pharmaceuticals ranks #471 out of 954 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Akums Drugs and Pharmaceuticals has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Akums Drugs and Pharmaceuticals' Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Akums Drugs and Pharmaceuticals ranks #471 out of 954 companies for Net Margin %. This puts Akums Drugs and Pharmaceuticals in the upper half of its industry. The industry median Net Margin % is 5.70. Akums Drugs and Pharmaceuticals' value of 7.31% is 28.4% above this benchmark. While the company's 10-year median is 3.64 vs. the industry median of 5.70, Akums Drugs and Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.70, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Akums Drugs and Pharmaceuticals's current Net Margin % of 7.31% is 28.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Akums Drugs and Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akums Drugs and Pharmaceuticals's current Net Margin % is 7.31%, which is 101% above median its own 10-year median of 3.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akums Drugs and Pharmaceuticals stock overvalued right now?
Akums Drugs and Pharmaceuticals (NSE:AKUMS) has a current Net Margin % of 7.31%. The current Net Margin % is 7.31%, which is 101% above median its 10-year median of 3.64 and 28.4% above the Drug Manufacturers industry median of 5.70. Akums Drugs and Pharmaceuticals' overall GF Score™ is 39/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Akums Drugs and Pharmaceuticals (NSE:AKUMS), the current Net Margin % is 7.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Akums Drugs and Pharmaceuticals Business Description
Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). It operates in five segments: Contract Development and Manufacturing Operations, Active Pharmaceutical Ingredient (API), Domestic Branded formulations, International Branded Formulations, and Trade generics. Key revenue is generated from Contract Development and Manufacturing Operations.
39GF Score
Get the complete analysis for NSE:AKUMS
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AKUMS has been successfully added to your 
